RaySearch Laboratories AB
USPTO PatentsView assignee record - 57 granted patents across 11 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).
The verdict
According to USPTO PatentsView, Raysearch ranks #5,975 of 49,997 tracked US assignees by granted-patent volume, with 57 patents across 11 technology areas.
- #5,975
- of 49,997 US assignees by volume
- Top 36%
- by Innovation Score (40.1/100)
- 13.8
- avg claims per patent
- +200%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5975 · Foreign Corporation #5,975 · 57 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 57 grants
- UPPER-Q #5,975/49,997
- PHOTO-FINISH Pangu BioPharma
- CPC-FOCUS A61N · 11 areas
- INNOV-PAR 40.1/100
- CLAIMS-RICH 13.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +200% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Pangu BioPharma Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Raysearch’s 40.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Raysearch
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Evalve · near
Evalve · near
40 score
- Huf North America… · near
Huf North America… · near
40 score
- Indian Industries · near
Indian Industries · near
40 score
- RaySearch Laboratori… · this assignee
RaySearch Laboratori… · this assignee
40 score
- Edwards Lifesciences… · near
Edwards Lifesciences… · near
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Raysearch's Innovation Score is 40.1/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Raysearch?
Each dot is one of Raysearch’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Raysearch’s own 13.8 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Raysearch's grants concentrate
RaySearch Laboratories AB is a focused PatentsView assignee: 11 CPC subclasses with 91.2% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2021 (9 grants) versus a trough of 2 in 2016. By volume, Raysearch sits between Pangu BioPharma Limited and Shandong NEW Beiyang Information Technology Co., Ltd..
Raysearch's three-year grant acceleration
From 2019–2021 to 2022–2024, RaySearch Laboratories AB moved from 24 to 22 grants (0.92x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Who files at RaySearch's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Pangu Biopharma
Pangu BioPharma Limited
57 patents
- Poly-med
Poly-Med, Inc.
57 patents
- Production Resour…
Production Resource Group, L.L.C.
57 patents
- Quantenna Communi…
Quantenna Communications, Inc.
57 patents
- Rhode Island Hosp…
Rhode Island Hospital
57 patents
- Robin Systems
Robin Systems, Inc.
57 patents
- Schuler Pressen
Schuler Pressen GMBH
57 patents
- Shandong NEW Beiy…
Shandong NEW Beiyang Information Technology Co., Ltd.
57 patents
- Raysearch Laborat… ◀
RaySearch Laboratories AB
57 patents
What this shows RaySearch holds 57 patents at rank #5,973, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near RaySearch
By rank, the assignees closest to #5,973 in granted patent volume.
- Pangu BioPharma Limited #5,969 · 57 patents
- Poly-Med, Inc. #5,970 · 57 patents
- Production Resource Group, L.L.C. #5,971 · 57 patents
- Quantenna Communications, Inc. #5,972 · 57 patents
- Rhode Island Hospital #5,974 · 57 patents
- Robin Systems, Inc. #5,975 · 57 patents
- Schuler Pressen GMBH #5,976 · 57 patents
- Shandong NEW Beiyang Information Technology Co., Ltd. #5,977 · 57 patents
Leaders in A61N (Electrotherapy)
Other assignees with the most granted patents in RaySearch's primary technology class.
- Medtronic, Inc. 2,200 in class
- Boston Scientific Neuromodulation Corporation 1,080 in class
- Cardiac Pacemakers, Inc. 1,037 in class
- Pacesetter, Inc. 609 in class
- Zoll Medical Corporation 556 in class
- Koniniklijke Philips N.V. 534 in class
- Cochlear Limited 449 in class
- Varian Medical Systems, Inc. 296 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for RaySearch, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), RaySearch ranks #71 of 1,943 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (40 here).
Similar claim depth
Nearest assignees by average claims per patent (13.8 here).
Raysearch's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 36% higher than 64% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 2 | 3.5% |
| 2017 | 2 | 3.5% |
| 2018 | 2 | 3.5% |
| 2019 | 7 | 12.3% |
| 2020 | 8 | 14.0% |
| 2021 | 9 | 15.8% |
| 2022 | 8 | 14.0% |
| 2023 | 8 | 14.0% |
| 2024 | 6 | 10.5% |
| 2025partial year | 5 | 8.8% |
Which technologies does RaySearch Laboratories AB patent most?
Top 11 of 11 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
RaySearch Laboratories AB's patent record in context - here's where to go next.
- RaySearch Laboratories AB's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 91.2% of its portfolio - see every assignee active in that class. Explore A61N
- Ranked #5,975 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare RaySearch Laboratories AB against Pangu BioPharma Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.